Petra Evenäs, PhD

Director, Clinical Trial Disclosure & Transparency at Genmab A/S

Speaker

Petra Evenäs, Director of Clinical Trial Disclosure & Transparency at Genmab, is responsible for public disclosure of clinical trial information and results. She has worked in the pharmaceutical industry for >20 years and is devoted to clinical trial transparency since 2014. In this context, Petra has established effective frameworks of disclosure at two companies, and in 2017, her contribution was recognized with LEO Pharma being ranked in 2^nd position in AllTrials’ global audit, assessing industry commitments to increase access to clinical trials information. Petra holds an MSc in Chemistry and a PhD in Experimental Clinical Chemistry.